• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于局部给药的液体紫杉醇的临床前研究:一项试点研究。

Pre-Clinical Investigation of Liquid Paclitaxel for Local Drug Delivery: A Pilot Study.

作者信息

Cawthon Claire V, Cooper Kathryn, Huett Clifton, Lloret Alyssa, Villar-Matamoros Estefanny, Stokes Lauren, Christians Uwe, Schuler Michele, Yazdani Saami K

机构信息

Department of Mechanical Engineering, University of South Alabama, Mobile, AL 36688, USA.

Department of Engineering, Wake Forest University, Winston-Salem, NC 27101, USA.

出版信息

Pharmaceuticals (Basel). 2020 Nov 28;13(12):434. doi: 10.3390/ph13120434.

DOI:10.3390/ph13120434
PMID:33260517
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7760562/
Abstract

The purpose of this pilot study was to investigate the feasibility of a perfusion catheter to deliver liquid paclitaxel into arterial segments. A clinically relevant rabbit ilio-femoral injury model was utilized to determine the impact of liquid paclitaxel delivered locally into the vessel wall using a perfusion catheter at 1 h to 14 days. Treatment by two clinically available forms of liquid paclitaxel, a solvent-based (sb) versus an albumin-bound (nab), along with a control (uncoated balloons), were investigated. Pharmacokinetic results demonstrated an increase in the retention of the sb-paclitaxel versus the nab-paclitaxel at 1 h; however, no other differences were observed at days one, three, and seven. Histological findings at 14 days showed significantly less neointimal area in the sb-paclitaxel treated arteries as compared with the nab-paclitaxel and the uncoated balloon-treated arteries. Additionally, percent area stenosis was significantly less in the sb-paclitaxel group. These results support the concept of local liquid delivery of paclitaxel into the arterial segments.

摘要

这项初步研究的目的是探讨灌注导管将液态紫杉醇输送至动脉节段的可行性。利用一种临床相关的兔髂股损伤模型,来确定在1小时至14天期间,使用灌注导管将液态紫杉醇局部输送至血管壁的影响。研究了两种临床可用的液态紫杉醇形式,即溶剂型(sb)与白蛋白结合型(nab),以及对照(未涂层球囊)的治疗效果。药代动力学结果表明,在1小时时,sb-紫杉醇的滞留量相对于nab-紫杉醇有所增加;然而,在第1天、第3天和第7天未观察到其他差异。14天时的组织学结果显示,与nab-紫杉醇和未涂层球囊治疗的动脉相比,sb-紫杉醇治疗的动脉新生内膜面积显著更小。此外,sb-紫杉醇组的面积狭窄百分比显著更低。这些结果支持了将紫杉醇局部液体输送至动脉节段的概念。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb77/7760562/9a309af040a5/pharmaceuticals-13-00434-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb77/7760562/55acd60332c0/pharmaceuticals-13-00434-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb77/7760562/68c31aa01641/pharmaceuticals-13-00434-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb77/7760562/5d30ec25fe39/pharmaceuticals-13-00434-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb77/7760562/88e2255e73a9/pharmaceuticals-13-00434-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb77/7760562/9a309af040a5/pharmaceuticals-13-00434-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb77/7760562/55acd60332c0/pharmaceuticals-13-00434-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb77/7760562/68c31aa01641/pharmaceuticals-13-00434-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb77/7760562/5d30ec25fe39/pharmaceuticals-13-00434-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb77/7760562/88e2255e73a9/pharmaceuticals-13-00434-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb77/7760562/9a309af040a5/pharmaceuticals-13-00434-g005.jpg

相似文献

1
Pre-Clinical Investigation of Liquid Paclitaxel for Local Drug Delivery: A Pilot Study.用于局部给药的液体紫杉醇的临床前研究:一项试点研究。
Pharmaceuticals (Basel). 2020 Nov 28;13(12):434. doi: 10.3390/ph13120434.
2
Pre-Clinical Investigation of Keratose as an Excipient of Drug Coated Balloons.临床前研究角鲨烷作为药物涂层球囊的赋形剂。
Molecules. 2020 Mar 31;25(7):1596. doi: 10.3390/molecules25071596.
3
The use of an occlusion perfusion catheter to deliver paclitaxel to the arterial wall.使用闭塞灌注导管将紫杉醇输送到动脉壁。
Cardiovasc Ther. 2017 Aug;35(4). doi: 10.1111/1755-5922.12269.
4
Inhibition of neo-intimal hyperplasia in porcine coronary arteries utilizing a novel paclitaxel-coated scoring balloon catheter.利用新型紫杉醇涂层刻痕球囊导管抑制猪冠状动脉新生内膜增生。
Catheter Cardiovasc Interv. 2014 Dec 1;84(7):1089-98. doi: 10.1002/ccd.25296. Epub 2013 Dec 20.
5
Paclitaxel-iopromide coated balloon followed by "bail-out" bare metal stent in porcine iliofemoral arteries: first report on biological effects in peripheral circulation.紫杉醇-碘普罗胺涂层球囊后继“ bailout”裸金属支架在猪髂股动脉中的应用:外周循环中生物学效应的首次报告。
EuroIntervention. 2011 Jul;7(3):362-8. doi: 10.4244/EIJV7I3A61.
6
[Prevention of restenosis in the canine coronary stents through local delivery of paclitaxel using the double-balloon perfusion catheter].通过双球囊灌注导管局部递送紫杉醇预防犬冠状动脉支架再狭窄
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2012 Feb;34(1):8-13.
7
Pre-clinical investigation of liquid sirolimus for local drug delivery.用于局部给药的液体西罗莫司的临床前研究。
Front Cardiovasc Med. 2023 Sep 15;10:1184816. doi: 10.3389/fcvm.2023.1184816. eCollection 2023.
8
Local delivery of paclitaxel using the double-balloon perfusion catheter before stenting in the porcine coronary artery.在猪冠状动脉内支架置入术前,使用双球囊灌注导管进行紫杉醇的局部递送。
Catheter Cardiovasc Interv. 2001 Aug;53(4):562-8. doi: 10.1002/ccd.1223.
9
Weekly nanoparticle albumin-bound paclitaxel in combination with cisplatin versus weekly solvent-based paclitaxel plus cisplatin as first-line therapy in Chinese patients with advanced esophageal squamous cell carcinoma.纳米白蛋白结合型紫杉醇联合顺铂周疗与溶剂型紫杉醇联合顺铂周疗作为中国晚期食管鳞状细胞癌患者一线治疗的比较
Onco Targets Ther. 2016 Sep 23;9:5663-5669. doi: 10.2147/OTT.S108580. eCollection 2016.
10
Monitoring of gadolinium-BOPTA uptake into the vessel wall during magnetic resonance (MR)-guided angioplasty of the peripheral arteries with a paclitaxel/gadolinium-BOPTA-coated balloon: an experimental study at 3 Tesla.使用紫杉醇/钆-双胺戊酸钆-二乙三胺五醋酸(Gd-BOPTA)涂层球囊在3特斯拉磁场下对外周动脉进行磁共振(MR)引导血管成形术期间监测钆-双胺戊酸钆-二乙三胺五醋酸在血管壁中的摄取:一项实验研究
Rofo. 2014 Apr;186(4):388-93. doi: 10.1055/s-0033-1355543. Epub 2013 Oct 18.

引用本文的文献

1
The Impact of Peripheral Vascular Motion on Acute Drug Retention of Intravascular Devices.外周血管运动对血管内装置急性药物滞留的影响
Cardiovasc Eng Technol. 2025 Feb 13. doi: 10.1007/s13239-025-00776-z.
2
Design and use of an ex vivo peripheral simulating bioreactor system for pharmacokinetic analysis of a drug coated stent.用于药物涂层支架药代动力学分析的体外外周模拟生物反应器系统的设计与应用。
Bioeng Transl Med. 2023 Nov 2;9(2):e10618. doi: 10.1002/btm2.10618. eCollection 2024 Mar.
3
Pre-clinical investigation of liquid sirolimus for local drug delivery.

本文引用的文献

1
Pre-Clinical Investigation of Keratose as an Excipient of Drug Coated Balloons.临床前研究角鲨烷作为药物涂层球囊的赋形剂。
Molecules. 2020 Mar 31;25(7):1596. doi: 10.3390/molecules25071596.
2
Risk of Death and Amputation with Use of Paclitaxel-Coated Balloons in the Infrapopliteal Arteries for Treatment of Critical Limb Ischemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.紫杉醇涂层球囊在治疗严重肢体缺血的腘动脉以下动脉中的应用与死亡和截肢风险:一项随机对照试验的系统评价和荟萃分析。
J Vasc Interv Radiol. 2020 Feb;31(2):202-212. doi: 10.1016/j.jvir.2019.11.015. Epub 2020 Jan 15.
3
Engineered collagen-binding serum albumin as a drug conjugate carrier for cancer therapy.
用于局部给药的液体西罗莫司的临床前研究。
Front Cardiovasc Med. 2023 Sep 15;10:1184816. doi: 10.3389/fcvm.2023.1184816. eCollection 2023.
4
Understanding the Mechanism of Drug Transfer and Retention of Drug-Coated Balloons.了解药物涂层球囊药物传递和保留的机制。
J Cardiovasc Pharmacol Ther. 2022 Jan-Dec;27:10742484221119559. doi: 10.1177/10742484221119559.
5
Precision delivery of liquid therapy into the arterial wall for the treatment of peripheral arterial disease.将液体疗法精确递送至动脉壁以治疗外周动脉疾病。
Sci Rep. 2021 Sep 21;11(1):18676. doi: 10.1038/s41598-021-98063-z.
工程化胶原结合型血清白蛋白作为一种用于癌症治疗的药物偶联物载体。
Sci Adv. 2019 Aug 14;5(8):eaaw6081. doi: 10.1126/sciadv.aaw6081. eCollection 2019 Aug.
4
Critical review and evidence implications of paclitaxel drug-eluting balloons and stents in peripheral artery disease.紫杉醇药物洗脱球囊和支架在周围动脉疾病中的关键评价和证据影响。
J Vasc Surg. 2019 Jul;70(1):3-7. doi: 10.1016/j.jvs.2019.05.002.
5
Risk of Death Following Application of Paclitaxel-Coated Balloons and Stents in the Femoropopliteal Artery of the Leg: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.紫杉醇涂层球囊和支架在下肢股腘动脉中的应用死亡风险:随机对照试验的系统评价和荟萃分析。
J Am Heart Assoc. 2018 Dec 18;7(24):e011245. doi: 10.1161/JAHA.118.011245.
6
Comparison of Biologic Effect and Particulate Embolization after Femoral Artery Treatment with Three Drug-Coated Balloons in Healthy Swine Model.健康猪模型中三种药物涂层球囊治疗股动脉后生物效应与微粒栓塞的比较
J Vasc Interv Radiol. 2019 Jan;30(1):103-109. doi: 10.1016/j.jvir.2018.07.025. Epub 2018 Dec 7.
7
and Assessment of Keratose as a Novel Excipient of Paclitaxel Coated Balloons.角质作为紫杉醇涂层球囊新型辅料的评估
Front Pharmacol. 2018 Jul 30;9:808. doi: 10.3389/fphar.2018.00808. eCollection 2018.
8
Coating and Pharmacokinetic Evaluation of Air Spray Coated Drug Coated Balloons.空气喷雾包衣药物涂层球囊的包衣及药代动力学评价
Cardiovasc Eng Technol. 2018 Jun;9(2):240-250. doi: 10.1007/s13239-018-0346-1. Epub 2018 Mar 1.
9
Nitinol Stents in the Femoropopliteal Artery: A Mechanical Perspective on Material, Design, and Performance.镍钛诺支架在股浅动脉中的应用:从材料、设计和性能的力学角度探讨
Ann Biomed Eng. 2018 May;46(5):684-704. doi: 10.1007/s10439-018-1990-1. Epub 2018 Feb 22.
10
The use of an occlusion perfusion catheter to deliver paclitaxel to the arterial wall.使用闭塞灌注导管将紫杉醇输送到动脉壁。
Cardiovasc Ther. 2017 Aug;35(4). doi: 10.1111/1755-5922.12269.